The joint-gut axis in inflammatory bowel diseases (Q37814551)

23 August 2017

1 reference

title

The joint-gut axis in inflammatory bowel diseases (English)

1 reference

inflammatory bowel diseases

23 August 2017

0 references

0 references

4

Tom W J Huizinga

1 reference

23 August 2017

Lianne K P M Brakenhoff

1

1 reference

23 August 2017

Désirée M van der Heijde

2

1 reference

23 August 2017

Daniel W Hommes

3

1 reference

23 August 2017

Herma H Fidder

5

1 reference

23 August 2017

language of work or name

1 reference

30 November 2009

1 reference

Journal of Crohn's and Colitis

23 August 2017

1 reference

23 August 2017

4

1 reference

23 August 2017

257-268

1 reference

23 August 2017

3

1 reference

THE EXTRA-INTESTINAL COMPLICATIONS OF CROHNʼS DISEASE AND ULCERATIVE COLITIS: A STUDY OF 700 PATIENTS

23 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.11.005

Association of extraintestinal manifestations of inflammatory bowel disease in a province of western Hungary with disease phenotype: Results of a 25-year follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.11.005

Peripheral arthropathies in inflammatory bowel disease: their articular distribution and natural history

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.11.005

The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.11.005

Ankylosing spondylitis and inflammatory bowel disease. II. Prevalence of peripheral arthritis, sacroiliitis, and ankylosing spondylitis in patients suffering from inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.11.005

The prevalence and incidence of peripheral arthritis in patients with inflammatory bowel disease, a prospective population-based study (the IBSEN study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.11.005

Inflammatory bowel disease arthropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.11.005

European evidence based consensus on the diagnosis and management of Crohn's disease: special situations

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.11.005

Ankylosing spondylitis and bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.11.005

Clinical History as a Screening Test for Ankylosing Spondylitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.11.005

Inflammatory back pain in ankylosing spondylitis: a reassessment of the clinical history for application as classification and diagnostic criteria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.11.005

Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.11.005

Analysing chronic spinal changes in ankylosing spondylitis: a systematic comparison of conventional x rays with magnetic resonance imaging using established and new scoring systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.11.005

New criteria for inflammatory back pain in patients with chronic back pain: a real patient exercise by experts from the Assessment of SpondyloArthritis international Society (ASAS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.11.005

The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part I): classification of paper patients by expert opinion including uncertainty appraisal.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.11.005

The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.11.005

Review article: joint involvement in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.11.005

21 January 2018

Enteropathic arthritis

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.11.005

Antibodies against cyclic citrullinated peptide (CCP) in inflammatory bowel disease patients with or without arthritic manifestations

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.11.005

Musculoskeletal manifestations of inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.11.005

The challenge of diagnosis and classification in early ankylosing spondylitis: do we need new criteria?

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.11.005

The diagnostic value of scintigraphy in assessing sacroiliitis in ankylosing spondylitis: a systematic literature research

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.11.005

Defining active sacroiliitis on magnetic resonance imaging (MRI) for classification of axial spondyloarthritis: a consensual approach by the ASAS/OMERACT MRI group

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.11.005

Lymphocyte homing to the gut: attraction, adhesion, and commitment

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.11.005

Blood microcirculation in the lymph node during the primary immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.11.005

The effects of antigen on the migration of recirculating lymphocytes through single lymph nodes

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.11.005

Points of control in inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.11.005

Dual binding capacity of mucosal immunoblasts to mucosal and synovial endothelium in humans: dissection of the molecular mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.11.005

Identical T-cell expansions in the colon mucosa and the synovium of a patient with enterogenic spondyloarthropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.11.005

Homing of mucosal leukocytes to joints. Distinct endothelial ligands in synovium mediate leukocyte-subtype specific adhesion

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.11.005

Human leukocyte subpopulations from inflamed gut bind to joint vasculature using distinct sets of adhesion molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.11.005

A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.11.005

The immunological and genetic basis of inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.11.005

Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.11.005

Nod-like receptors in innate immunity and inflammatory diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.11.005

Crohn's disease-associated NOD2 variants share a signaling defect in response to lipopolysaccharide and peptidoglycan

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.11.005

How NOD2 mutations predispose to Crohn's disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.11.005

Radiological sacroiliitis, a hallmark of spondylitis, is linked with CARD15 gene polymorphisms in patients with Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.11.005

CARD15 gene polymorphisms in patients with spondyloarthropathies identify a specific phenotype previously related to Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.11.005

Inflammatory bowel disease and spondylarthropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.11.005

Histopathology of intestinal inflammation related to reactive arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.11.005

Spontaneous inflammatory disease in transgenic rats expressing HLA-B27 and human beta 2m: an animal model of HLA-B27-associated human disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.11.005

The germfree state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.11.005

HLA class I associations of ankylosing spondylitis in the white population in the United Kingdom.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.11.005

Ankylosing spondylitis and undifferentiated spondyloarthropathies: a clinical review and description of a disease subset with older age at onset.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.11.005

HLA-B27-restricted CD8 T cells derived from synovial fluids of patients with reactive arthritis and ankylosing spondylitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.11.005

Major histocompatibility genes and ankylosing spondylitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.11.005

Macrophages expressing the scavenger receptor CD163: a link between immune alterations of the gut and synovial inflammation in spondyloarthropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.11.005

Colon mucosa of patients both with spondyloarthritis and Crohn's disease is enriched with macrophages expressing the scavenger receptor CD163.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.11.005

Subclinical gut inflammation in spondyloarthropathy patients is associated with upregulation of the E-cadherin/catenin complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.11.005

Indications and challenges of probiotics, prebiotics, and synbiotics in the management of arthralgias and spondyloarthropathies in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.11.005

Distinctive activated cellular subsets in colon from patients with Crohn's disease and ulcerative colitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.11.005

Do NSAIDs, antibiotics, infections, or stress trigger flares in IBD?

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.11.005

Exacerbation of inflammatory bowel diseases associated with the use of nonsteroidal anti-inflammatory drugs: myth or reality?

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.11.005

Safety of celecoxib in patients with ulcerative colitis in remission: a randomized, placebo-controlled, pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.11.005

An open-label trial of the selective cyclo-oxygenase-2 inhibitor, rofecoxib, in inflammatory bowel disease-associated peripheral arthritis and arthralgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.11.005

Safety of selective cyclooxygenase-2 inhibitors in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.11.005

The gastrointestinal safety and effect on disease activity of etoricoxib, a selective cox-2 inhibitor in inflammatory bowel diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.11.005

ASAS/EULAR recommendations for the management of ankylosing spondylitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.11.005

Successful treatment of active ankylosing spondylitis with the anti-tumor necrosis factor alpha monoclonal antibody infliximab

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.11.005

Repeated infusions of infliximab, a chimeric anti-TNFalpha monoclonal antibody, in patients with active spondyloarthropathy: one year follow up

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.11.005

Randomized double-blind comparison of chimeric monoclonal antibody to tumor necrosis factor alpha (infliximab) versus placebo in active spondylarthropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.11.005

Structure-modifying capacity of anti-tumour necrosis factor-alpha therapy in ankylosing spondylitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.11.005

Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.11.005

Infliximab in spondyloarthropathy associated with Crohn's disease: an open study on the efficacy of inducing and maintaining remission of musculoskeletal and gut manifestations

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.11.005

Infliximab in the treatment of extra-intestinal manifestations of Crohn's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.11.005

Immunomodulatory effects of etanercept on peripheral joint synovitis in the spondylarthropathies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.11.005

Etanercept for active Crohn's disease: a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.11.005

Efficacy of etanercept for treatment of Crohn's related spondyloarthritis but not colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.11.005

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.11.005

Physical function, disease activity, and health-related quality-of-life outcomes after 3 years of adalimumab treatment in patients with ankylosing spondylitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.11.005

Adalimumab: in Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.11.005

Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.11.005

Role ofNOD2 variants in spondylarthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.11.005

Musculoskeletal Manifestations in a Population-based Cohort of Inflammatory Bowel Disease Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.11.005

10.1016/J.CROHNS.2009.11.005

21 January 2018

Identifiers

DOI

1 reference

23 August 2017

1 reference